These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 5136016)

  • 1. [Effect of Clofibrate on disorders in lipid metabolism. I].
    Szybiński Z; Lankosz J; Kieta-Fyda A; Bobrowski A; Biczowa N; Mareczek S
    Przegl Lek; 1971 Oct; 28(10):668-71. PubMed ID: 5136016
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in the spectrum of serum lipids following 3 months administration of clofibrate Spofa].
    Cagánova A; Cagan S
    Cesk Farm; 1971 Nov; 20(9):341-6. PubMed ID: 5136172
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of a lipid-reducing clofibrate-inositolnicotinate combination compared to clofibrate. A double-blind study].
    Schäfer B; Kluthe R
    Med Welt; 1975 Apr; 26(14):655-63. PubMed ID: 1099394
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative double-blind study on the normolipemic effect of clofibrate and a clofibrate-mucopolysaccharide extract combination].
    Cagli V; Lillo V
    Clin Ter; 1975 Oct; 75(2):153-69. PubMed ID: 132333
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic effect of clofibrate in a patient with primary hyperlipoproteinemia type 3].
    Plamieniak L
    Wiad Lek; 1974 May; 27(9):811-4. PubMed ID: 4849978
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical and biological study of a new vascular protective agent and hypolipemic agent, pyridoxine para-chloro-phénoxy-isobutyrate. (Claresan)].
    Fourrier A; Mouton Y
    Lille Med; 1974 Apr; 19(4 Suppl 11):532-7. PubMed ID: 4612283
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical experimentation with RU 19,(83 (Dabical) calcium clofibrate].
    Pauchant M; Bourbillon JP
    Lille Med; 1976 Jan; 21(1 suppl 1):24-8. PubMed ID: 1256229
    [No Abstract]   [Full Text] [Related]  

  • 8. [Influence of a combined treatment using clofibrate and persantin persantinat on increased serum lipid levels].
    Hammerl H; Nebosis G; Pichler O; Studlar M
    Med Welt; 1973 Mar; 24(12):468-70. PubMed ID: 4700881
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lipid-lowering effect of a combination of clofibrate and DL-alpha-tocopherol nicotinate in unselected hyperlipemic patients].
    Gniwotta E; Herter B
    ZFA (Stuttgart); 1977 Apr; 53(10):565-8. PubMed ID: 324162
    [No Abstract]   [Full Text] [Related]  

  • 10. [Lipid metabolism disorders and deafness of the inner ear. Therapeutic approaches: clinical testing of clofibrate (Lipavlon: I.C.I. Pharma laboratories)].
    Martin PH; Oudot J
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1977 Nov; 26(9):725-8. PubMed ID: 146069
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of hyperlipidemia in patients with ischemic heart disease].
    Haviar V; Kusá O; Riecanský I; Luknárová O
    Vnitr Lek; 1972 Jun; 18(6):586-91. PubMed ID: 5044447
    [No Abstract]   [Full Text] [Related]  

  • 12. [Long-term management of various hyperlipidemias using clofibrate].
    Studlar M; Pichler O; Kindler K
    Wien Med Wochenschr; 1975 Dec; 125(50-52):746-51. PubMed ID: 1229130
    [No Abstract]   [Full Text] [Related]  

  • 13. [Liapten--a new lipid depressor. Clinical experience in lipid metabolism disorders].
    Fodor GP
    ZFA (Stuttgart); 1978 Jan; 54(1):49-55. PubMed ID: 622856
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of hyperlipidemias. Value of a new hypolipidemic drug clofibride, (M-G. 46)].
    Leutenegger M; Choisy H; Caron J; Paris H
    Therapie; 1974; 29(4):599-610. PubMed ID: 4439371
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of clofibrate on unsaturated fatty acids in lipid fractions of sera in patients with hyperlipemia].
    Felt V; Husek P
    Vnitr Lek; 1976 Mar; 22(3):256-61. PubMed ID: 1266086
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study of clofibrate. The opinion of Prof. D. Kritchevsky].
    Fabbrocini V
    Minerva Cardioangiol; 1980 Nov; 28(11):759-60. PubMed ID: 7231692
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experimentation with Atherulip 500 (apropos of 30 cases)].
    Jaillard J
    Lille Med; 1976 Dec; 21 Suppl 4():915-8. PubMed ID: 1018618
    [No Abstract]   [Full Text] [Related]  

  • 18. Some clinical potentials of chlorophenoxyisobutyrate (Clofibrate) therapy. (Hyperlipidemia--angina pectoris--blood sludging--diabetic neuropathy).
    Duncan GG; Elliott FA; Duncan TG; Schatanoff J
    Trans Am Clin Climatol Assoc; 1968; 79():216-28. PubMed ID: 5760587
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of hyperlipidemias by RU 19,583 (Dabical)].
    Creff AF
    Med Chir Dig; 1975; 4(3):197-200. PubMed ID: 1219237
    [No Abstract]   [Full Text] [Related]  

  • 20. [Correction of lipid exchange with heparin and miscleron in patients with ischemic heart disease].
    Mamchenko GF
    Vrach Delo; 1979 Mar; (3):43-6. PubMed ID: 452529
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.